• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT SECTIONS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • VIDEOS

Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?

November 19, 2024 By SPINEMarketGroup

In recent years, Globus Medical has pursued a clear and ambitious goal: becoming the leader in the spine market. Meanwhile, Medtronic Spine has focused on defending its position against Globus. This strategic battle has driven significant moves that are reshaping the industry’s landscape.

Globus Medical’s Strategy: From Challenger to Contender

Globus faced two major challenges in achieving leadership. First, it needed a strategic acquisition to gain the market share required to compete directly with Medtronic. The purchase of NuVasive addressed this need, propelling Globus from fifth to second place in the market rankings. Second, the company had to ensure a seamless integration of NuVasive to solidify its position and drive further growth.

Initially, this acquisition raised concerns on Wall Street, as past deals in the spine market had failed to deliver. However, Globus’s recent performance has alleviated these fears. Its stock has rebounded to the $80 per share level seen before the purchase, signaling confidence in its strategy. Today, the question is no longer if Globus will catch up to Medtronic but whether it already has.

A Tight Race: Sales and Market Shares

Looking at the first nine months of the year, Globus Medical and Medtronic report similar revenues, each around $1.8 billion. However, there are nuances to consider:

  • Different fiscal calendars: Globus reports data for January–September 2024, while Medtronic’s results cover February–October (Q4 of 2024 and Q1–Q2 of 2025). This timing difference complicates direct comparisons.
  • Combined Cranial & Spine reporting by Medtronic: Historically, Spine represents approximately 51% of this segment, which adds some uncertainty to the comparison.

Despite these differences, it’s clear that Globus is now very close to Medtronic (if it hasn’t surpassed it already).As for market shares, the current standings place Medtronic and Globus Medical in a tie for leadership, each holding 25%. Trailing behind, Stryker overtook Johnson & Johnson (J&J) for third place with 12%, while J&J fell to fourth with 10%.

J&J: Sell, Acquire, or Stagnate?

J&J’s decline from second to fourth place in just a few years highlights a significant loss of competitiveness in this critical market. This raises important questions about the company’s future in the spine segment. Three scenarios are possible:

  1. Selling the Spine Business
    Given its declining performance, J&J may view this segment as non-core and opt to sell it, reallocating resources to more profitable areas. This move could simplify its portfolio and generate capital for growth initiatives. Potential buyers: Stryker could solidify its hold on third place, or smaller players might seize the opportunity to scale up rapidly.
  2. Acquiring to Regain Leadership
    Alternatively, J&J could pursue acquisitions to revitalize its position in the market. This strategy would require significant financial investment and flawless execution in integrating new companies—something Globus successfully demonstrated with NuVasive.
  3. Stagnation or Gradual Exit
    Should J&J decide to maintain the status quo, it risks further market share erosion and irrelevance against more dynamic competitors.

Our Opinion

The current scenario suggests that J&J is likely to divest its spine business. This aligns with a broader trend among corporations simplifying their portfolios to focus on high-growth, high-return areas, such as digital health or precision medicine. However, the decision will depend on internal factors (business performance, strategic priorities) and external ones (sale opportunities, competitive landscape).

As Globus and Medtronic compete neck and neck for leadership, Johnson & Johnson faces a pivotal moment that will shape its role in this rapidly evolving market.

(Visited 6,568 times, 488 visits today)

Filed Under: ARTICLES, NEWS Tagged With: 2024

Reader Interactions

Comments

  1. Anonymous says

    November 22, 2024 at 4:21 pm

    I’m sure 👍 but

  2. Ahmed Hassan El-Naggary says

    November 23, 2024 at 12:27 am

    J & J needs:
    To trust itself as – used to be – one of the market leader and this needs to come from the board members first.
    Professional leaders to turn the line to its previous strength thru building up a worriers team members believe in themselves to be back strongly.
    Change its – noticed on land strategy – from a focused accounts policy to entire market’s accounts penteration, account by account, area by area, country by country, region by region.
    Effective and sufficient Rescue studied plan to reach a recovery outcomes on determined phases.
    “more details need to be sorted out for the above”

  3. Drew says

    December 5, 2024 at 1:56 pm

    A big miss here….Globus reports all business units together. Spine, Cranial, Ortho, Enabling Tech, Instruments.

Primary Sidebar

PLATINUM SPONSORS

GOLD SPONSORS

MOST POPULAR POSTS

  • BROCHURES
  • Just Reflective, Not Disappointed: Globus Medical’s…
  • What’s Happening with Globus Medical? Why Has the…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • The Crown Is Still Medtronic’s… For Now!
  • (UPDATED 2024): +8 Lumbar Artificial Discs to Know…
  • Globus Medical to Execute $500 Million Share Buyback…
  • Stryker’s Spine Business Sale: A Smart Move or a…
  • After Diabetes, Could Medtronic’s Spine…
  • Globus Medical extends versatility of Advanced…
  • Eminent Spine’s 3D Printed Titanium Pedicle Screw…
  • Dispute Over Spinal Implant Royalties Between…
  • M6 Discontinued: What Are the Alternatives for a…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • Alphatec Today: Where It Stands and Where It’s Heading?
  • (Updated!) 15 Expandable PLIF Cages to Know…!
  • (UPDATED 2024): +108 Stand-Alone Cervical Cages to Know..!
  • Globus Medical Reports First Quarter 2025 Results
  • Stryker’s Spine Exit: What It Means for…
  • Viscogliosi Brothers Completes Acquisition of U.S.…
  • LAST 10 VIDEOS PUBLISHED

    1. Biedermann Motech: MOSS 100 (Short)
    2. POWEHI MEDICAL AG: KUDOS™ Modular
    3. POWEHI MEDICAL AG: TANTO® Screw
    4. Syntropiq: Taurus TLIF (Short)
    5. LEM Surgical: Dynamis Surgical Robot
    6. Aegis Spine:PathLoc-TA
    7. NGMedical: MOVE®-C Artificial Disc
    8. B.Braun Aesculap: Ennovate® Cervical MIS
    9. Spineart: PERLA® TL Deformity Solutions
    10. NGMedical: MOVE®-C

    Recent Comments

    • Peter on A New Player in Spinal Care, POWEHI Medical!
    • Sandy on Just Reflective, Not Disappointed: Globus Medical’s Bittersweet Q1 2025
    • SPINEMarketGroup on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Sergio López-Fombona on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Drew on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Ahmed Hassan El-Naggary on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Email
    • Twitter
    • YouTube

    Subscribe to Our Newsletter!

    Check your inbox or spam folder to confirm your subscription.

    Footer

    • Email
    • Twitter
    • YouTube

    Contact us:

    [email protected] [email protected]

    PRIVATE POLICY

    • Legal Advice
    • Embed Link
    • VIDEOS

    Copyright © 2025 · SPINEMarketGroup

    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    View preferences
    {title} {title} {title}